The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
PRIMAQUINE: REPORT FROM CDC EXPERT MEETING ON MALARIA CHEMOPROPHYLAXIS I
Open accessAbstract
Primaquine phosphate has been used for preventing relapse of Plasmodium vivax and P. ovale malaria since the early 1950s, based on its ability to kill latent (hypnozoite) and developing liver stages of these parasites. There are three uses for primaquine in malaria: radical cure of established infection with P. vivax or P. ovale malaria; presumptive anti-relapse therapy (PART; terminal prophylaxis) in persons with extensive exposure to these parasites; and primary prophylaxis against all malaria species. All persons for whom primaquine is being considered must have a glucose-6-phosphate dehydrogenase (G6PD) enzyme level checked before use, and persons who have a deficiency of G6PD must not take primaquine for prophylaxis or PART. The recommended adult dose for PART based on clinical trials and expert opinion is 30 mg base daily for 14 days, started on return from a malarious region and overlapping with a blood schizonticide. The adult dose for primary prophylaxis is 30 mg daily begun 1 day before travel and continued for 7 days after return. This review will examine the evidence for these recommendations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Report of the Committee on Infectious Diseases
Nider, H. (1989) · Archives of Dermatology · doi:10.1001/archderm.1989.01670190156031 · Cited by 1,911
Drugs in Pregnancy and Lactation
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-11-902_3 · Cited by 1,075
(2001) · PsycEXTRA Dataset · doi:10.1037/e548252006-001 · Cited by 1,018
McEvoy, G. K. (1994) · Oncology Issues · doi:10.1080/10463356.1994.11904493 · Cited by 888
Primaquine Therapy for Malaria
Baird, J. K., & Hoffman, S. L. (2004) · Clinical Infectious Diseases · doi:10.1086/424663 · Cited by 435
Self-citationGlucose-6-Phosphate Dehydrogenase Deficiency
Desforges, J. F., & Beutler, E. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101173240306 · Cited by 430
Drug Prescribing in Renal Failure: Dosing Guidelines for Adults.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-502_4 · Cited by 360
Inhibition and induction of human cytochrome P450 (CYP) enzymes
PELKONEN, O., MÄEENPÄEÄ, J., TAAVITSAINEN, P., RAUTIO, A., & RAUNIO, H. (1998) · Xenobiotica · doi:10.1080/004982598238886 · Cited by 358
Medina, I., Mills, J., Leoung, G., Hopewell, P. C., Lee, B., Modin, G., Benowitz, N., & Wofsy, C. B. (1990) · New England Journal of Medicine · doi:10.1056/nejm199009203231202 · Cited by 320
Guide to Development of Practice Guidelines
Kish, M. A. (2001) · Clinical Infectious Diseases · doi:10.1086/319366 · Cited by 276
Cited by
Bousema, T., & Drakeley, C. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00051-10 · Cited by 746
Primaquine revisited six decades after its discovery
Vale, N., Moreira, R., & Gomes, P. (2009) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.08.011 · Cited by 367
Imaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug Discovery
Meister, S., Plouffe, D. M., Kuhen, K. L., Bonamy, G. M. C., Wu, T., Barnes, S. W., Bopp, S. E., Borboa, R., Bright, A. T., Che, J., et al. (2011) · Science · doi:10.1126/science.1211936 · Cited by 338
The Practice of Travel Medicine: Guidelines by the Infectious Diseases Society of America
Hill, D. R., Ericsson, C. D., Pearson, R. D., Keystone, J. S., Freedman, D. O., Kozarsky, P. E., DuPont, H. L., Bia, F. J., Fischer, P. R., & Ryan, E. T. (2006) · Clinical Infectious Diseases · doi:10.1086/508782 · Cited by 296
Self-citationUK malaria treatment guidelines
Lalloo, D. G., Shingadia, D., Pasvol, G., Chiodini, P. L., Whitty, C. J., Beeching, N. J., Hill, D. R., Warrell, D. A., & Bannister, B. A. (2007) · Journal of Infection · doi:10.1016/j.jinf.2006.12.003 · Cited by 272
Self-citationNeglect of Plasmodium vivax malaria
Baird, J. K. (2007) · Trends in Parasitology · doi:10.1016/j.pt.2007.08.011 · Cited by 266
Self-citationResistance to Therapies for Infection by Plasmodium vivax
Baird, J. K. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00008-09 · Cited by 262
Self-citationAntimalarial drug resistance in Africa: the calm before the storm?
Conrad, M. D., & Rosenthal, P. J. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30261-0 · Cited by 255
Xuan, J., Chen, S., Ning, B., Tolleson, W. H., & Guo, L. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.10.009 · Cited by 103
Metadata
- Authors
- HILL, D. R., BAIRD, J. K., PARISE, M. E., LEWIS, L. S., RYAN, E. T., & MAGILL, A. J.
- Venue
- The American Journal of Tropical Medicine and Hygiene
- Published
- 2006-09
- Volume
- 75
- Issue
- 3
- Pages
- 402-415
- ISSN
- 0002-9637 (ISSN-L)
- OpenAlex
- W2004295690
- Cited by
- 334
- References
- 57
- FWCI
- 16.16
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.